In the last trading session, 1.87 million shares of the Biofrontera Inc (NASDAQ:BFRI) were traded, and its beta was 0.52. Most recently the company’s share price was $0.96, and it changed around -$0.2 or -17.24% from the last close, which brings the market valuation of the company to $5.32M. BFRI currently trades at a discount to its 52-week high of $8.99, offering almost -836.46% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 36.46% since then. We note from Biofrontera Inc’s average daily trading volume that its 10-day average is 0.61 million shares, with the 3-month average coming to 270.64K.
Biofrontera Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended BFRI as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. Biofrontera Inc is expected to report earnings per share of -0.83 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biofrontera Inc (NASDAQ:BFRI) trade information
Instantly BFRI has showed a red trend with a performance of -17.24% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.3400 on recent trading dayincreased the stock’s daily price by 28.36%. The company’s shares are currently down -65.34% year-to-date, but still down -25.00% over the last five days. On the other hand, Biofrontera Inc (NASDAQ:BFRI) is -14.29% down in the 30-day period. We can see from the shorts that 0.13 million shares have been sold at a short interest cover period of 0.39 day(s).
Biofrontera Inc (BFRI) estimates and forecasts
Biofrontera Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -46.96 percent over the past six months and at a 81.51% annual growth rate that is well above the industry average of 17.60%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 82.10% in revenue this quarter, and will report a decrease of -106.10% in the next quarter. The year-over-year growth rate is expected to be 16.80%, up from the previous year.
Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 10.01M in revenue for the current quarter. 2 analysts expect Biofrontera Inc to make 14.05M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 8.9M and 10.6M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 12.50%. Forecasts for the next quarter put sales growth at 32.60%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.90%.
BFRI Dividends
Biofrontera Inc’s next quarterly earnings report is expected to be released in November.
Biofrontera Inc (NASDAQ:BFRI)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 32.06% of Biofrontera Inc shares, and 35.64% of them are in the hands of institutional investors. The stock currently has a share float of 52.46%.
